Cargando…
Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study
Although the efficacy of propranolol for the treatment of infantile hemangiomas (IHs) has been well documented, there is a paucity of clinical data regarding the safety and tolerance of propranolol in neonates. A prospective study of 51 patients less than 30 days of age with severe IH was conducted....
Autores principales: | Ji, Yi, Chen, Siyuan, Xiang, Bo, Yang, Yang, Qiu, Liqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431448/ https://www.ncbi.nlm.nih.gov/pubmed/28473717 http://dx.doi.org/10.1038/s41598-017-01321-2 |
Ejemplares similares
-
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Neonatal Abdominal Hemangiomatosis: Propranolol beyond Infantile Hemangioma
por: Nip, Siu Ying Angel, et al.
Publicado: (2016) -
Severe hypoglycemia in propranolol treatment for infantile hemangiomas
por: Morimoto, Akira, et al.
Publicado: (2022) -
Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management
por: Ji, Yi, et al.
Publicado: (2018) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)